New imaging system to guide heart procedure
Part of Heart & circulation clinical trials.
This study tests a new imaging system that helps doctors see inside the heart during a procedure to treat atrial fibrillation (an irregular heartbeat). It may allow for more precise treatment and improve outcomes for people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 22 years old
- You have been diagnosed with paroxysmal or persistent atrial fibrillation (a type of irregular heartbeat)
- You are scheduled to have a catheter ablation procedure (a treatment that uses heat or cold to fix irregular heartbeats)
- You have not had heart surgery or a heart attack in the last 6 months
- You have not had a prior ablation for atrial fibrillation (except for a simple treatment for atrial flutter)
- You do not have a pacemaker or defibrillator (except a loop recorder)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new navigation and imaging system called VERAFEYE that helps doctors perform catheter ablation (a procedure to fix irregular heartbeats) more precisely. It may help people with paroxysmal atrial fibrillation get a safer and more effective treatment.
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
This study tests a new imaging system (VERAFEYE) that helps doctors guide catheter ablation, a procedure to fix irregular heartbeats like atrial fibrillation. It aims to see if the system makes the procedure safer or more effective.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
Hear when a new Paroxysmal Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.